🇪🇺 Cotellic in European Union

EMA authorised Cotellic on 20 November 2015

Marketing authorisation

EMA — authorised 20 November 2015

  • Status: approved

Cotellic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Cotellic approved in European Union?

Yes. EMA authorised it on 20 November 2015.

Who is the marketing authorisation holder for Cotellic in European Union?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.